| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lapatinib | CCLE | pan-cancer | AAC | 0.25 | 6e-07 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.26 | 3e-05 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.2 | 0.0001 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | 0.2 | 0.0002 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.13 | 0.0002 |
| mRNA | WZ3105 | GDSC1000 | pan-cancer | AAC | 0.12 | 0.0003 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.21 | 0.001 |
| mRNA | KIN001-102 | GDSC1000 | pan-cancer | AAC | 0.1 | 0.001 |